Financial results for Q 4 and year ended 31.03.2025 is submitted
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.1 pts more than Nifty Microcap 250 and 4.9 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
HOCL swung to a standalone net profit of Rs 39,154 lakhs (consolidated: Rs 51,968 lakhs) in FY25 from a loss of Rs 5,532 lakhs in FY24, but the turnaround is entirely driven by a one-time exceptional gain of Rs 50,275 lakhs from the Government of India waiving long-outstanding loans, preference shares, interest, and penal interest. Underlying operations actually weakened: revenue fell 22.5% from Rs 72,058 lakhs to Rs 55,862 lakhs, and operating loss widened from Rs 5,532 lakhs to Rs 10,788 lakhs. The statutory auditor issued an unmodified opinion but flagged multiple emphasis-of-matter items, including non-functional audit committee, board composition non-compliance with SEBI LODR, the going-concern assumption, and a new Rs 4,307 lakh contingent liability arising from a Mumbai High Court order on mesne profits.
The headline profit masks continued core-business weakness and is entirely dependent on a non-recurring government waiver. While total borrowings dropped sharply from Rs 73,888 lakhs to Rs 51,990 lakhs, shareholders should weigh governance concerns (audit committee did not review results, board not compliant with SEBI norms) and the fact that the chemicals business remains loss-making at the operating level.